PFKFB2 Is Pivotal for Metabolic Flexibility and Differential Glucose Utilization
Open Access
- 18 November 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (22) , e043921
Abstract
Background: The heart’s constant energy demands make metabolic flexibility critical to its function as nutrient availability varies. The enzyme phosphofructokinase‐2/fructose 2,6‐bisphosphatase (PFKFB2) contributes to this flexibility by acting as a positive or negative regulator of cardiac glycolysis. We have previously shown that PFKFB2 is degraded in the diabetic heart and that a cardiac‐specific PFKFB2 knockout (cKO) impacts ancillary glucose pathways and mitochondrial substrate preference. Therefore, defining PFKFB2’s role in mitochondrial metabolic flexibility is paramount to understanding both metabolic homeostasis and metabolic syndromes. Further, it is unknown how PFKFB2 loss impacts the heart’s response to acute stress. Here, we examined how cardiac mitochondrial flexibility and the posttranslational modification O‐GlcNAcylation are affected in cKO mice in response to fasting or pharmacologic stimulation. Methods: cKO and litter‐matched controls were euthanized in the fed or fasted (12 hours) states, with or without a 20‐minute stimulant stress of caffeine and epinephrine. Mitochondrial respiration, metabolomics, and changes to systemic glucose homeostasis were evaluated. Results: cKO mice had moderate impairment in mitochondrial metabolic flexibility, affecting downstream glucose oxidation, respiration, and carnitine palmitoyl transferase 1 activity. O‐GlcNAcylation, a product of ancillary glucose metabolism, was upregulated in cKO hearts in the fed state, but this was ameliorated in the fasted state. Furthermore, metabolic remodeling in response to PFKFB2 loss was sufficient to impact circulating glucose in fasted and stressed states. Conclusions: PFKFB2 is essential for fed‐to‐fasted changes in cardiac metabolism and plays an important regulatory role in protein O‐GlcNAcylation. Its loss also affects systemic glucose homeostasis under stressed conditions.Keywords
All Related Versions
This publication has 92 references indexed in Scilit:
- Differential Detection of O-GlcNAcylated proteins in the heart using antibodiesAnalytical Biochemistry, 2023
- Hyperglycemia regulates cardiac K+ channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathwaysBasic Research in Cardiology, 2020
- GC–MS metabolic profiling reveals fructose-2,6-bisphosphate regulates branched chain amino acid metabolism in the heart during fastingMetabolomics, 2019
- Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of FastingObesity, 2017
- Fuel availability and fate in cardiac metabolism: A tale of two substratesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2016
- O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificityAmino Acids, 2014
- O-linked β-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- The role of protein O-linked β-N-acetylglucosamine in mediating cardiac stress responsesBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Mechanisms responsible for regulation of pyruvate dehydrogenase kinase 4 gene expressionAdvances in Enzyme Regulation, 2004
- Insulin and Ischemia Stimulate Glycolysis by Acting on the Same Targets Through Different and Opposing Signaling PathwaysJournal of Molecular and Cellular Cardiology, 2002